Instrument Inactif

Autres langues Helius Medical Technologies, Inc. Toronto S.E.

Actions

HSM

US42328V6039

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)	15:00
Top Premarket Gainers	03/05
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation	25/04
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center	24/04
Top Premarket Gainers	03/04
Helius Medical Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Helius Medical Technologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Reports Q4 Revenue $134,000	28/03
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024	15/03
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke	12/03
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke	12/03
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference	07/03
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller	04/03
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller	04/03
Traders Await Fresh Cues After Powell's Rate-Cut Commentary, Stifling US Equity Futures Pre-Bell	06/02
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Earnings Flow Intensifies	06/02
Top Premarket Gainers	06/02
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients	06/02
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS	05/02
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital	11/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Helius Medical Technologies, Inc. Toronto S.E.

Actions

HSM

US42328V6039

Autres langues

Filtres